{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:00:20Z","timestamp":1775232020968,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.7759\/cureus.106378","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:20:28Z","timestamp":1775229628000},"source":"Crossref","is-referenced-by-count":0,"title":["A Comparison Between Bisphosphonates and Teriparatide in the Treatment of Postmenopausal Osteoporosis: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Russaal S","family":"Mann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayushi","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupanshu","family":"Rupanshu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo S","family":"Chavez Cavalie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202309_33586","article-title":"Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials","volume":"27","author":"Wang WY","year":"2023","unstructured":"Wang WY, Chen LH, Ma WJ, You RX. Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials. Eur Rev Med Pharmacol Sci. 2023, 27:8253-68. 10.26355\/eurrev_202309_33586","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1431676","article-title":"Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis","volume":"15","author":"Yang J","year":"2024","unstructured":"Yang J, Guo X, Cui Z, Guo H, Dong JN. Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024, 15:1431676. 10.3389\/fendo.2024.1431676","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2021.11.015","article-title":"Importance of time point-specific indirect treatment comparisons of osteoporosis treatments: a systematic literature review and network meta-analyses","volume":"44","author":"Willems D","year":"2022","unstructured":"Willems D, Javaid MK, Pinedo-Villanueva R, Libanati C, Yehoshua A, Charokopou M. Importance of time point-specific indirect treatment comparisons of osteoporosis treatments: a systematic literature review and network meta-analyses. Clin Ther. 2022, 44:81-97. 10.1016\/j.clinthera.2021.11.015","journal-title":"Clin Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-024-01447-7","article-title":"Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Li M","year":"2024","unstructured":"Li M, Ge Z, Zhang B, Sun L, Wang Z, Zou T, Chen Q. Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials. Arch Osteoporos. 2024, 19:89. 10.1007\/s11657-024-01447-7","journal-title":"Arch Osteoporos"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3384","article-title":"Effects of teriparatide compared with risedronate on the risk of fractures in subgroups of postmenopausal women with severe osteoporosis: the VERO trial","volume":"33","author":"Geusens P","year":"2018","unstructured":"Geusens P, Marin F, Kendler DL, et al.. Effects of teriparatide compared with risedronate on the risk of fractures in subgroups of postmenopausal women with severe osteoporosis: the VERO trial. J Bone Miner Res. 2018, 33:783-94. 10.1002\/jbmr.3384","journal-title":"J Bone Miner Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115574","article-title":"Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis","volume":"140","author":"Ebina K","year":"2020","unstructured":"Ebina K, Hirao M, Tsuboi H, et al.. Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis. Bone. 2020, 140:115574. 10.1016\/j.bone.2020.115574","journal-title":"Bone"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73068","article-title":"Clinical efficacy and safety of teriparatide versus alendronate in postmenopausal osteoporosis: a systematic review of randomized controlled trials","volume":"16","author":"Nunkoo S","year":"2024","unstructured":"Nunkoo S, Krissheeven M, Chitravanshi A, Ramanah M, Robinson J, Banerjee I. Clinical efficacy and safety of teriparatide versus alendronate in postmenopausal osteoporosis: a systematic review of randomized controlled trials. Cureus. 2024, 16:e73068. 10.7759\/cureus.73068","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14245\/ns.2347256.628","article-title":"Comparison of the clinical efficacy of anabolic agents and bisphosphonates in the patients with osteoporotic vertebral fracture: systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Jeon I","year":"2024","unstructured":"Jeon I, Park SB, Moon BJ, Choi M, Kuh SU, Kim J. Comparison of the clinical efficacy of anabolic agents and bisphosphonates in the patients with osteoporotic vertebral fracture: systematic review and meta-analysis of randomized controlled trials. Neurospine. 2024, 21:416-29. 10.14245\/ns.2347256.628","journal-title":"Neurospine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05463-4","article-title":"Efficacy of teriparatide compared with risedronate on FRAX(\u00ae)-defined major osteoporotic fractures: results of the VERO clinical trial","volume":"31","author":"Body JJ","year":"2020","unstructured":"Body JJ, Marin F, Kendler DL, et al.. Efficacy of teriparatide compared with risedronate on FRAX(\u00ae)-defined major osteoporotic fractures: results of the VERO clinical trial. Osteoporos Int. 2020, 31:1935-42. 10.1007\/s00198-020-05463-4","journal-title":"Osteoporos Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1530\/EOR-23-0205","article-title":"Teriparatide in postmenopausal osteoporosis: uncovering novel insights into efficacy and safety compared to other treatments - a systematic review and meta-analysis","volume":"9","author":"Arthur Vithran DT","year":"2024","unstructured":"Arthur Vithran DT, Essien AE, Rahmati M, et al.. Teriparatide in postmenopausal osteoporosis: uncovering novel insights into efficacy and safety compared to other treatments - a systematic review and meta-analysis. EFORT Open Rev. 2024, 9:845-61. 10.1530\/EOR-23-0205","journal-title":"EFORT Open Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-022-01131-8","article-title":"Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study","volume":"17","author":"Li M","year":"2022","unstructured":"Li M, Zhang Z, Xue Q, et al.. Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study. Arch Osteoporos. 2022, 17:103. 10.1007\/s11657-022-01131-8","journal-title":"Arch Osteoporos"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.22540\/JRPMS-04-008","article-title":"Coadministration of zoledronic acid and teriparatide in postmenopausal osteoporosis","volume":"4","author":"Zidrou C","year":"2020","unstructured":"Zidrou C, Beletsiotis A. Coadministration of zoledronic acid and teriparatide in postmenopausal osteoporosis. J Res. 2020, 4:8-14. 10.22540\/JRPMS-04-008","journal-title":"J Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/os.12959","article-title":"Vertebral collapse prevented following teriparatide treatment in postmenopausal K\u00fcmmell's disease patients with severe osteoporosis","volume":"13","author":"Gou PG","year":"2021","unstructured":"Gou PG, Zhao ZH, Zhou JM, et al.. Vertebral collapse prevented following teriparatide treatment in postmenopausal K\u00fcmmell's disease patients with severe osteoporosis. Orthop Surg. 2021, 13:506-16. 10.1111\/os.12959","journal-title":"Orthop Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-024-01541-3","article-title":"Predictors of discontinuation of osteoporosis treatment: sub-analysis of the Japanese osteoporosis intervention trial-05 (JOINT-05)","volume":"42","author":"Takeuchi Y","year":"2024","unstructured":"Takeuchi Y, Nakatsuka Y, Tanaka S, Kuroda T, Hagino H, Mori S, Soen S. Predictors of discontinuation of osteoporosis treatment: sub-analysis of the Japanese osteoporosis intervention trial-05 (JOINT-05). J Bone Miner Metab. 2024, 42:675-80. 10.1007\/s00774-024-01541-3","journal-title":"J Bone Miner Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-06066-3","article-title":"Correction to: a randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05","volume":"32","author":"Hagino H","year":"2021","unstructured":"Hagino H, Sugimoto T, Tanaka S, et al.. Correction to: a randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05. Osteoporos Int. 2021, 32:2143. 10.1007\/s00198-021-06066-3","journal-title":"Osteoporos Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis JA","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019, 30:3-44. 10.1007\/s00198-018-4704-5","journal-title":"Osteoporos Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update","volume":"26","author":"Camacho PM","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, et al.. American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract. 2020, 26:1-46. 10.4158\/GL-2020-0524SUPPL","journal-title":"Endocr Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/421510-a-comparison-between-bisphosphonates-and-teriparatide-in-the-treatment-of-postmenopausal-osteoporosis-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:20:29Z","timestamp":1775229629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/421510-a-comparison-between-bisphosphonates-and-teriparatide-in-the-treatment-of-postmenopausal-osteoporosis-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.106378","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,3]]}}}